China Heart Pump Device Market Size & Outlook, 2025-2033
China Heart Pump Device Market Insights
- According to Reed Intelligence analysis, the China Heart Pump Device Market size was USD 248.65 Million in 2024 and is projected to reach USD 1450.55 Million by 2033.
- The China market is projected to grow at a CAGR of 21.3% between 2026 and 2033.
- By segment, Intra-Aortic Balloon Pumps emerged as the largest By Product in terms of market size in 2024.
- Intra-Aortic Balloon Pumps is anticipated to remain the most attractive By Product segment, recording the fastest growth during the forecast period.
![China Heart Pump Device Market Size, Share & Growth Analysis By [2033]](https://reedintelligence.com/uploads/charts/china-heart-pump-device-market-china-by-product-34307.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- China contributed 14.54% to the global Heart Pump Device Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Heart Pump Device Market.
- In Asia Pacific, China is projected to capture the leading share of market size by 2033.
- Among Asia Pacific markets, Australia is expected to post the fastest growth, reaching USD 222.43 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 248.65 Million |
| Market Size In 2033 | USD 1450.55 Million |
| Largest segment | Intra-Aortic Balloon Pumps |
| Units | Revenue in USD Million |
| CAGR | 21.3% (2025-2033) |
| Segmnetation Covered | |
| By Product |
|
| By Type |
|
| By Therapy |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Heart Pump Device Market By Product 2025-2033 (USD Million)
| By Product | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intra-Aortic Balloon Pumps | XX.x | XX.x | XX.x | 130.94 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ventricular Assist Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total Artificial Heart | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Heart Pump Device Market By Type 2025-2033 (USD Million)
| By Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Implantable Heart Pump Devices | XX.x | XX.x | XX.x | 161.4 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Extracorporeal Heart Pump Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Heart Pump Device Market By Therapy 2025-2033 (USD Million)
| By Therapy | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bridge-to-transplant (BTT) | XX.x | XX.x | XX.x | 109.03 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Bridge-to-candidacy (BTC) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Destination Therapy (DT) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Therapies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.